LTFS
AXDX

Ladenburg Thalmann Financial Services’s Accelerate Diagnostics AXDX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2K Hold
10
– – ﹤0.01% 5037
2019
Q3 		$2K Buy
+10
New +$1.93K ﹤0.01% 4931
2017
Q3 		– Sell
-160
Closed -$44K – 4924
2017
Q2 		$44K Sell
160
-55
-26% -$14.9K ﹤0.01% 3114
2017
Q1 		$52K Buy
215
+160
+291% +$36.6K ﹤0.01% 2874
2016
Q4 		$11K Buy
55
+35
+175% +$8.31K ﹤0.01% 3808
2016
Q3 		$5K Buy
+20
New +$4.42K ﹤0.01% 4129

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Ladenburg Thalmann Financial Services's AXDX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Accelerate Diagnostics (AXDX) position steady in Q4 2019 at 10 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #5037.

Ladenburg Thalmann Financial Services first reported a position in AXDX in Q3 2016 and has held it in 6 quarters since. The position peaked at $52K in Q1 2017. 109 funds tracked by Wall St. Rank hold AXDX as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 10 shares of Accelerate Diagnostics worth $2K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Accelerate Diagnostics share count unchanged in Q4 2019.
  • Accelerate Diagnostics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5037 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Accelerate Diagnostics in Q3 2016 and has held it in 6 quarters since.
  • Ladenburg Thalmann Financial Services's Accelerate Diagnostics position peaked at $52K in Q1 2017.
  • 109 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.